Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis.
Jiwon M LeeJae Won YangAndreas KronbichlerMichael EisenhutGaeun KimKeum Hwa LeeYoun Ho ShinPublished in: Journal of immunology research (2019)
Our meta-analysis demonstrated that, in comparison to both healthy controls and controls with minimal change disease, suPAR levels were significantly higher in adult patients with pFSGS. suPAR levels did not differ between pFSGS patients during the initial period of diagnosis and those in remission.